Astrana Health, Inc. (ASTH) 10-Year Financial Performance & Capital Metrics

ASTH • • Industrial / General

HealthcareHealthcare FacilitiesSpecialized Medical ServicesPrimary Care Management

AboutAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Show more

Revenue $2.03B +46.7%
EBITDA $117M +14.6%
Net Income $43M -28.9%
EPS (Diluted) 0.90 -30.2%
Gross Margin 13.34% -14.0%
EBITDA Margin 5.76% -21.9%
Operating Margin 4.39% -28.0%
Net Margin 2.12% -51.6%
ROE 9.33% -25.5%
ROIC 11.8% -12.8%
Debt/Equity 0.92 +17.4%
Interest Coverage 2.70 -48.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 25.0%
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 29.4%
✓Efficient asset utilization: 1.5x turnover

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y29.41%

3Y38.01%

TTM68.17%

Profit (Net Income) CAGR

10Y-

5Y25.04%

3Y-14.45%

TTM-84.73%

EPS CAGR

10Y-

5Y18.2%

3Y-16.03%

TTM-110.77%

ROCE

10Y Avg4.74%

5Y Avg9.84%

3Y Avg11.6%

Latest10.49%

Peer Comparison

Primary Care Management

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ASTHAstrana Health, Inc.	1.37B	27.38	30.42	46.72%	0.33%	1.72%	3.22%	0.92
PIIIP3 Health Partners Inc.	10.85M	3.30	-0.06	18.48%	-9.07%	-6.92%		1.11
AGLAgilon Health, Inc.	422.87M	1.02	-1.62	40.41%	-5.24%	-100.71%		0.09

Profit & Loss

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	44.05M	357.75M	519.91M	560.62M	370.25M	773.91M	1.14B	1.39B	2.03B
Revenue Growth %	-	7.12%	0.45%	0.08%	-0.34%	1.09%	0.48%	0.21%	0.47%
Cost of Goods Sold+	34.35M	293.73M	380.44M	467.81M	348.54M	596.14M	944.68M	1.17B	1.76B
COGS % of Revenue	0.78%	0.82%	0.73%	0.83%	0.94%	0.77%	0.83%	0.84%	0.87%
Gross Profit+	9.7M	64.02M	139.47M	92.81M	21.7M	177.77M	199.48M	214.96M	271.39M
Gross Margin %	0.22%	0.18%	0.27%	0.17%	0.06%	0.23%	0.17%	0.16%	0.13%
Gross Profit Growth %	-	5.6%	1.18%	-0.33%	-0.77%	7.19%	0.12%	0.08%	0.26%
Operating Expenses+	16.28M	26.44M	47.24M	60.39M	15.62M	79.59M	95.21M	130.34M	182.04M
OpEx % of Revenue	0.37%	0.07%	0.09%	0.11%	0.04%	0.1%	0.08%	0.09%	0.09%
Selling, General & Admin	16.28M	26.44M	47.24M	41.48M	15.59M	62.08M	77.67M	112.6M	154.11M
SG&A % of Revenue	0.37%	0.07%	0.09%	0.07%	0.04%	0.08%	0.07%	0.08%	0.08%
Research & Development	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	18.91M	26K	17.52M	17.54M	17.75M	27.93M
Operating Income+	-6.58M	37.58M	92.23M	32.42M	6.09M	98.18M	104.27M	84.61M	89.35M
Operating Margin %	-0.15%	0.11%	0.18%	0.06%	0.02%	0.13%	0.09%	0.06%	0.04%
Operating Income Growth %	-	6.71%	1.45%	-0.65%	-0.81%	15.13%	0.06%	-0.19%	0.06%
EBITDA+	-6.23M	56.65M	111.53M	50.7M	24.44M	115.7M	121.81M	102.36M	117.28M
EBITDA Margin %	-0.14%	0.16%	0.21%	0.09%	0.07%	0.15%	0.11%	0.07%	0.06%
EBITDA Growth %	-	10.09%	0.97%	-0.55%	-0.52%	3.73%	0.05%	-0.16%	0.15%
D&A (Non-Cash Add-back)	351.4K	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M
EBIT	-7.7M	49.79M	83.19M	30.57M	11.39M	83.14M	94.54M	105.94M	113.92M
Net Interest Income+	-542.3K	935.51K	698K	-2.71M	-2.12M	-3.82M	-5.94M	-1.89M	-18.59M
Interest Income	0	1.02M	1.26M	2.02M	405K	1.57M	1.98M	14.21M	14.51M
Interest Expense	542.3K	79.69K	560.51K	4.73M	2.53M	5.39M	7.92M	16.1M	33.1M
Other Income/Expense	-1.66M	12.13M	-9.6M	-6.58M	2.78M	-20.43M	-17.65M	5.22M	-8.53M
Pretax Income+	-8.24M	49.71M	82.63M	25.84M	8.87M	77.75M	86.62M	89.84M	80.82M
Pretax Margin %	-0.19%	0.14%	0.16%	0.05%	0.02%	0.1%	0.08%	0.06%	0.04%
Income Tax+	-71.04K	3.89M	22.36M	8.17M	9.18M	31.69M	40.88M	31.99M	30.89M
Effective Tax Rate %	1.13%	0.52%	0.13%	0.55%	-2.68%	0.89%	0.52%	0.68%	0.53%
Net Income+	-9.34M	25.8M	10.84M	14.12M	-23.75M	68.92M	45.17M	60.72M	43.15M
Net Margin %	-0.21%	0.07%	0.02%	0.03%	-0.06%	0.09%	0.04%	0.04%	0.02%
Net Income Growth %	-	3.76%	-0.58%	0.3%	-2.68%	3.9%	-0.34%	0.34%	-0.29%
Net Income (Continuing)	-8.17M	45.82M	60.27M	17.67M	-314K	46.05M	45.74M	57.85M	49.93M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	2.74M	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M
EPS (Diluted)+	-1.79	0.90	0.29	0.39	1.01	1.52	0.99	1.29	0.90
EPS Growth %	-	1.5%	-0.68%	0.34%	1.59%	0.5%	-0.35%	0.3%	-0.3%
EPS (Basic)	0.00	1.01	0.33	0.41	1.04	1.57	1.00	1.30	0.91
Diluted Shares Outstanding	5.21M	28.66M	37.91M	36.4M	37.45M	45.4M	45.6M	47.07M	48.22M
Basic Shares Outstanding	1	25.53M	32.89M	34.71M	36.53M	43.83M	44.97M	46.71M	47.69M
Dividend Payout Ratio	-	0.4%	1.64%	4.37%	-	0.45%	0.31%	1.02%	0.09%

Balance Sheet

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	13.56M	144.16M	172.86M	329.07M	338.58M	404.46M	428.13M	461.51M	638.5M
Cash & Short-Term Investments	9.27M	120.92M	108.02M	219.73M	261.17M	286.51M	293.59M	296.31M	290.83M
Cash Only	9.27M	119.77M	106.89M	103.19M	193.47M	233.1M	288.03M	293.81M	288.45M
Short-Term Investments	0	1.14M	1.13M	116.54M	67.69M	53.42M	5.57M	2.5M	2.38M
Accounts Receivable	3.99M	20.12M	57.46M	98.95M	60.62M	99.31M	119.73M	147.75M	324.8M
Days Sales Outstanding	33.1	20.53	40.34	64.42	59.76	46.84	38.2	38.89	58.27
Inventory	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-
Other Current Assets	0	0	0	75K	0	0	14.8M	17.45M	22.86M
Total Non-Current Assets+	6.01M	346.48M	340.14M	399.64M	478.91M	462.9M	538.09M	471.85M	716.4M
Property, Plant & Equipment	1.25M	13.81M	12.72M	26.38M	48.46M	68.63M	128.98M	44.57M	46.88M
Fixed Asset Turnover	35.30x	25.90x	40.87x	21.25x	7.64x	11.28x	8.87x	31.11x	43.40x
Goodwill	1.62M	189.85M	185.81M	238.5M	239.05M	246.42M	269.05M	278.83M	419.25M
Intangible Assets	0	0	0	103.01M	86.98M	82.81M	76.86M	71.65M	118.18M
Long-Term Investments	530K	37.65M	53.53M	29.32M	80.37M	42.61M	42.7M	32.17M	48.22M
Other Non-Current Assets	254.37K	1.63M	1.21M	2.43M	19.41M	22.44M	4.56M	2.22M	63.22M
Total Assets+	19.57M	490.64M	513M	728.71M	817.49M	867.36M	966.21M	933.36M	1.35B
Asset Turnover	2.25x	0.73x	1.01x	0.77x	0.45x	0.89x	1.18x	1.49x	1.50x
Asset Growth %	-	24.08%	0.05%	0.42%	0.12%	0.06%	0.11%	-0.03%	0.45%
Total Current Liabilities+	7.43M	109.6M	72.02M	105.42M	114.99M	114.72M	148.61M	218.67M	365.61M
Accounts Payable	2.04M	27.18M	4.48M	6.91M	9.55M	5.51M	10.47M	9.07M	15.17M
Days Payables Outstanding	21.64	33.78	4.3	5.39	10.01	3.38	4.05	2.83	3.14
Short-Term Debt	188.76K	5.54M	40.26K	9.5M	10.89M	780K	619K	19.5M	9.38M
Deferred Revenue (Current)	110.65K	250K	1000K	1000K	1000K	1000K	531K	744K	1000K
Other Current Liabilities	2.88M	68.99M	41.75M	61.96M	67.09M	65.89M	113.24M	164M	257.74M
Current Ratio	1.82x	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x
Quick Ratio	1.82x	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.58M	44.72M	34.32M	262.23M	257.35M	242M	259.06M	303.92M	475.12M
Long-Term Debt	0	0	13M	232.17M	230.21M	182.92M	203.39M	258.94M	425.3M
Capital Lease Obligations	0	520.26K	517.26K	11.79M	16.18M	14.17M	21.19M	37.32M	31.26M
Deferred Tax Liabilities	43.48K	24.92M	19.62M	18.27M	10.96M	30.14M	14.22M	4.07M	4.55M
Other Non-Current Liabilities	3.54M	19.28M	1.19M	0	0	14.78M	20.26M	3.59M	14M
Total Liabilities	11.02M	154.32M	106.34M	367.65M	372.34M	356.72M	407.67M	522.59M	840.73M
Total Debt+	188.76K	6.25M	13.66M	256.55M	260.56M	200.98M	229.36M	321.01M	471.84M
Net Debt	-9.08M	-113.52M	-93.23M	153.36M	67.08M	-32.11M	-58.66M	27.21M	183.38M
Debt / Equity	0.02x	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x
Debt / EBITDA	-	0.11x	0.12x	5.06x	10.66x	1.74x	1.88x	3.14x	4.02x
Net Debt / EBITDA	-	-2.00x	-0.84x	3.02x	2.75x	-0.28x	-0.48x	0.27x	1.56x
Interest Coverage	-12.14x	471.56x	164.55x	6.85x	2.41x	18.20x	13.16x	5.25x	2.70x
Total Equity+	8.55M	336.31M	406.66M	361.06M	445.15M	510.64M	558.55M	410.77M	514.17M
Equity Growth %	-	38.33%	0.21%	-0.11%	0.23%	0.15%	0.09%	-0.26%	0.25%
Book Value per Share	1.64	11.73	10.73	9.92	11.89	11.25	12.25	8.73	10.66
Total Shareholders' Equity	5.81M	159.95M	180.55M	191.55M	330.82M	448.17M	542.56M	614.22M	712.72M
Common Stock	5.88K	32.3K	34.58K	36K	42K	45K	47K	47K	48K
Retained Earnings	-28.68M	1.73M	17.79M	31.91M	69.77M	137.25M	182.42M	243.13M	286.28M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-5.88K	0	0	0	0	0	0	0	0
Minority Interest	2.74M	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M

Cash Flow

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.84M	53.07M	26.1M	13.67M	46.16M	70.33M	82.13M	68.23M	52.2M
Operating CF Margin %	-0.04%	0.15%	0.05%	0.02%	0.12%	0.09%	0.07%	0.05%	0.03%
Operating CF Growth %	-	29.86%	-0.51%	-0.48%	2.38%	0.52%	0.17%	-0.17%	-0.23%
Net Income	-9.34M	25.8M	10.84M	17.67M	122.08M	46.05M	45.74M	57.85M	49.93M
Depreciation & Amortization	351.4K	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M
Stock-Based Compensation	0	0	0	1.55M	3.38M	6.75M	16.1M	22.04M	34.54M
Deferred Taxes	-127.73K	-20.68M	-8.35M	-6.8M	396K	7.67M	-14.28M	-12.44M	-4.25M
Other Non-Cash Items	4.05M	42.15M	157.26M	5.75M	-102.08M	25.98M	18.98M	6.42M	7.67M
Working Capital Changes	2.63M	15.98M	-63.05M	-22.77M	4.04M	-33.64M	-1.96M	-23.39M	-63.61M
Change in Receivables	272.4K	10.7M	-28.63M	-5.8M	3.01M	-21.63M	-33.97M	-20.57M	-11.1M
Change in Inventory	0	0	0	0	-7.71M	-2.11M	27.61M	12.15M	0
Change in Payables	1.02M	-1.81M	-22.67M	-4.39M	15.82M	4.11M	-2.52M	-498K	-30.43M
Cash from Investing+	-247.11K	6.73M	-25.76M	-180.63M	95.49M	16.54M	-7.11M	-65.52M	-192.4M
Capital Expenditures	-262.11K	-2.08M	-1.17M	-1.04M	-1.16M	-19.22M	-22.94M	-28.53M	-8.03M
CapEx % of Revenue	0.01%	0.01%	0%	0%	0%	0.02%	0.02%	0.02%	0%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	26.8M	-7.5M	-11.19M	16.41M	56K	4.47M	-23.8M	-25.74M
Cash from Financing+	6.34M	-14.98M	-11.2M	163.33M	-51.7M	-47.75M	-20.09M	3.42M	135.15M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-10.45M	-17.76M	-61.72M	-51.32M	-31.09M	-14.03M	-62.07M	-4.04M
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-954.49K	-9M	323	-2.62M	-1.04M	-1.42M	4.02M	-5.01M	-12.59M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.1M	50.99M	24.93M	12.63M	45M	51.11M	59.19M	39.7M	44.17M
FCF Margin %	-0.05%	0.14%	0.05%	0.02%	0.12%	0.07%	0.05%	0.03%	0.02%
FCF Growth %	-	25.27%	-0.51%	-0.49%	2.56%	0.14%	0.16%	-0.33%	0.11%
FCF per Share	-0.40	1.78	0.66	0.35	1.20	1.13	1.30	0.84	0.92
FCF Conversion (FCF/Net Income)	0.20x	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x
Interest Paid	176.59K	51.04K	462K	4.26M	8.51M	4.16M	6.67M	14.25M	30.42M
Taxes Paid	521.34K	24.36M	23.64M	20.2M	62M	37.2M	47.31M	56.57M	43.94M

Key Ratios

Metric	2015	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-109.27%	14.96%	2.92%	3.68%	-5.89%	14.42%	8.45%	12.53%	9.33%
Return on Invested Capital (ROIC)	-	25.36%	25.8%	5.87%	0.89%	14.86%	15.98%	13.53%	11.8%
Gross Margin	22.01%	17.89%	26.83%	16.56%	5.86%	22.97%	17.43%	15.5%	13.34%
Net Margin	-21.21%	7.21%	2.08%	2.52%	-6.42%	8.91%	3.95%	4.38%	2.12%
Debt / Equity	0.02x	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x
Interest Coverage	-12.14x	471.56x	164.55x	6.85x	2.41x	18.20x	13.16x	5.25x	2.70x
FCF Conversion	0.20x	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x
Revenue Growth	-	712.16%	45.33%	7.83%	-33.96%	109.03%	47.84%	21.19%	46.72%

Revenue by Segment

	2024
Health Care Capitation Revenue	1.86B
Health Care Capitation Revenue Growth	-
Health Care, Other	86.22M
Health Care, Other Growth	-
Health Care, Patient Service	62.33M
Health Care, Patient Service Growth	-
Product and Service, Other	15.22M
Product and Service, Other Growth	-
Management Service	13.98M
Management Service Growth	-

Frequently Asked Questions

Valuation & Price

Astrana Health, Inc. (ASTH) has a price-to-earnings (P/E) ratio of 30.4x. This suggests investors expect higher future growth.

Growth & Financials

Astrana Health, Inc. (ASTH) reported $2.90B in revenue for fiscal year 2024. This represents a 6476% increase from $44.0M in 2015.

Astrana Health, Inc. (ASTH) grew revenue by 46.7% over the past year. This is strong growth.

Yes, Astrana Health, Inc. (ASTH) is profitable, generating $9.5M in net income for fiscal year 2024 (2.1% net margin).

Dividend & Returns

Yes, Astrana Health, Inc. (ASTH) pays a dividend with a yield of 0.31%. This makes it attractive for income-focused investors.

Astrana Health, Inc. (ASTH) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.

Astrana Health, Inc. (ASTH) generated $97.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Astrana Health, Inc. (ASTH) 10-Year Financial Performance & Capital Metrics

ASTH • • Industrial / General

HealthcareHealthcare FacilitiesSpecialized Medical ServicesPrimary Care Management

Revenue $2.03B +46.7%
EBITDA $117M +14.6%
Net Income $43M -28.9%
EPS (Diluted) 0.90 -30.2%
Gross Margin 13.34% -14.0%
EBITDA Margin 5.76% -21.9%
Operating Margin 4.39% -28.0%
Net Margin 2.12% -51.6%
ROE 9.33% -25.5%
ROIC 11.8% -12.8%
Debt/Equity 0.92 +17.4%
Interest Coverage 2.70 -48.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 25.0%
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 29.4%
✓Efficient asset utilization: 1.5x turnover

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y29.41%

3Y38.01%

TTM68.17%

Profit (Net Income) CAGR

10Y-

5Y25.04%

3Y-14.45%

TTM-84.73%

EPS CAGR

10Y-

5Y18.2%

3Y-16.03%

TTM-110.77%

ROCE

10Y Avg4.74%

5Y Avg9.84%

3Y Avg11.6%

Latest10.49%

Peer Comparison

Primary Care Management

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ASTHAstrana Health, Inc.	1.37B	27.38	30.42	46.72%	0.33%	1.72%	3.22%	0.92
PIIIP3 Health Partners Inc.	10.85M	3.30	-0.06	18.48%	-9.07%	-6.92%		1.11
AGLAgilon Health, Inc.	422.87M	1.02	-1.62	40.41%	-5.24%	-100.71%		0.09

Profit & Loss

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	44.05M	357.75M	519.91M	560.62M	370.25M	773.91M	1.14B	1.39B	2.03B
Revenue Growth %	-	7.12%	0.45%	0.08%	-0.34%	1.09%	0.48%	0.21%	0.47%
Cost of Goods Sold+	34.35M	293.73M	380.44M	467.81M	348.54M	596.14M	944.68M	1.17B	1.76B
COGS % of Revenue	0.78%	0.82%	0.73%	0.83%	0.94%	0.77%	0.83%	0.84%	0.87%
Gross Profit+	9.7M	64.02M	139.47M	92.81M	21.7M	177.77M	199.48M	214.96M	271.39M
Gross Margin %	0.22%	0.18%	0.27%	0.17%	0.06%	0.23%	0.17%	0.16%	0.13%
Gross Profit Growth %	-	5.6%	1.18%	-0.33%	-0.77%	7.19%	0.12%	0.08%	0.26%
Operating Expenses+	16.28M	26.44M	47.24M	60.39M	15.62M	79.59M	95.21M	130.34M	182.04M
OpEx % of Revenue	0.37%	0.07%	0.09%	0.11%	0.04%	0.1%	0.08%	0.09%	0.09%
Selling, General & Admin	16.28M	26.44M	47.24M	41.48M	15.59M	62.08M	77.67M	112.6M	154.11M
SG&A % of Revenue	0.37%	0.07%	0.09%	0.07%	0.04%	0.08%	0.07%	0.08%	0.08%
Research & Development	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	18.91M	26K	17.52M	17.54M	17.75M	27.93M
Operating Income+	-6.58M	37.58M	92.23M	32.42M	6.09M	98.18M	104.27M	84.61M	89.35M
Operating Margin %	-0.15%	0.11%	0.18%	0.06%	0.02%	0.13%	0.09%	0.06%	0.04%
Operating Income Growth %	-	6.71%	1.45%	-0.65%	-0.81%	15.13%	0.06%	-0.19%	0.06%
EBITDA+	-6.23M	56.65M	111.53M	50.7M	24.44M	115.7M	121.81M	102.36M	117.28M
EBITDA Margin %	-0.14%	0.16%	0.21%	0.09%	0.07%	0.15%	0.11%	0.07%	0.06%
EBITDA Growth %	-	10.09%	0.97%	-0.55%	-0.52%	3.73%	0.05%	-0.16%	0.15%
D&A (Non-Cash Add-back)	351.4K	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M
EBIT	-7.7M	49.79M	83.19M	30.57M	11.39M	83.14M	94.54M	105.94M	113.92M
Net Interest Income+	-542.3K	935.51K	698K	-2.71M	-2.12M	-3.82M	-5.94M	-1.89M	-18.59M
Interest Income	0	1.02M	1.26M	2.02M	405K	1.57M	1.98M	14.21M	14.51M
Interest Expense	542.3K	79.69K	560.51K	4.73M	2.53M	5.39M	7.92M	16.1M	33.1M
Other Income/Expense	-1.66M	12.13M	-9.6M	-6.58M	2.78M	-20.43M	-17.65M	5.22M	-8.53M
Pretax Income+	-8.24M	49.71M	82.63M	25.84M	8.87M	77.75M	86.62M	89.84M	80.82M
Pretax Margin %	-0.19%	0.14%	0.16%	0.05%	0.02%	0.1%	0.08%	0.06%	0.04%
Income Tax+	-71.04K	3.89M	22.36M	8.17M	9.18M	31.69M	40.88M	31.99M	30.89M
Effective Tax Rate %	1.13%	0.52%	0.13%	0.55%	-2.68%	0.89%	0.52%	0.68%	0.53%
Net Income+	-9.34M	25.8M	10.84M	14.12M	-23.75M	68.92M	45.17M	60.72M	43.15M
Net Margin %	-0.21%	0.07%	0.02%	0.03%	-0.06%	0.09%	0.04%	0.04%	0.02%
Net Income Growth %	-	3.76%	-0.58%	0.3%	-2.68%	3.9%	-0.34%	0.34%	-0.29%
Net Income (Continuing)	-8.17M	45.82M	60.27M	17.67M	-314K	46.05M	45.74M	57.85M	49.93M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	2.74M	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M
EPS (Diluted)+	-1.79	0.90	0.29	0.39	1.01	1.52	0.99	1.29	0.90
EPS Growth %	-	1.5%	-0.68%	0.34%	1.59%	0.5%	-0.35%	0.3%	-0.3%
EPS (Basic)	0.00	1.01	0.33	0.41	1.04	1.57	1.00	1.30	0.91
Diluted Shares Outstanding	5.21M	28.66M	37.91M	36.4M	37.45M	45.4M	45.6M	47.07M	48.22M
Basic Shares Outstanding	1	25.53M	32.89M	34.71M	36.53M	43.83M	44.97M	46.71M	47.69M
Dividend Payout Ratio	-	0.4%	1.64%	4.37%	-	0.45%	0.31%	1.02%	0.09%

Balance Sheet

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	13.56M	144.16M	172.86M	329.07M	338.58M	404.46M	428.13M	461.51M	638.5M
Cash & Short-Term Investments	9.27M	120.92M	108.02M	219.73M	261.17M	286.51M	293.59M	296.31M	290.83M
Cash Only	9.27M	119.77M	106.89M	103.19M	193.47M	233.1M	288.03M	293.81M	288.45M
Short-Term Investments	0	1.14M	1.13M	116.54M	67.69M	53.42M	5.57M	2.5M	2.38M
Accounts Receivable	3.99M	20.12M	57.46M	98.95M	60.62M	99.31M	119.73M	147.75M	324.8M
Days Sales Outstanding	33.1	20.53	40.34	64.42	59.76	46.84	38.2	38.89	58.27
Inventory	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-
Other Current Assets	0	0	0	75K	0	0	14.8M	17.45M	22.86M
Total Non-Current Assets+	6.01M	346.48M	340.14M	399.64M	478.91M	462.9M	538.09M	471.85M	716.4M
Property, Plant & Equipment	1.25M	13.81M	12.72M	26.38M	48.46M	68.63M	128.98M	44.57M	46.88M
Fixed Asset Turnover	35.30x	25.90x	40.87x	21.25x	7.64x	11.28x	8.87x	31.11x	43.40x
Goodwill	1.62M	189.85M	185.81M	238.5M	239.05M	246.42M	269.05M	278.83M	419.25M
Intangible Assets	0	0	0	103.01M	86.98M	82.81M	76.86M	71.65M	118.18M
Long-Term Investments	530K	37.65M	53.53M	29.32M	80.37M	42.61M	42.7M	32.17M	48.22M
Other Non-Current Assets	254.37K	1.63M	1.21M	2.43M	19.41M	22.44M	4.56M	2.22M	63.22M
Total Assets+	19.57M	490.64M	513M	728.71M	817.49M	867.36M	966.21M	933.36M	1.35B
Asset Turnover	2.25x	0.73x	1.01x	0.77x	0.45x	0.89x	1.18x	1.49x	1.50x
Asset Growth %	-	24.08%	0.05%	0.42%	0.12%	0.06%	0.11%	-0.03%	0.45%
Total Current Liabilities+	7.43M	109.6M	72.02M	105.42M	114.99M	114.72M	148.61M	218.67M	365.61M
Accounts Payable	2.04M	27.18M	4.48M	6.91M	9.55M	5.51M	10.47M	9.07M	15.17M
Days Payables Outstanding	21.64	33.78	4.3	5.39	10.01	3.38	4.05	2.83	3.14
Short-Term Debt	188.76K	5.54M	40.26K	9.5M	10.89M	780K	619K	19.5M	9.38M
Deferred Revenue (Current)	110.65K	250K	1000K	1000K	1000K	1000K	531K	744K	1000K
Other Current Liabilities	2.88M	68.99M	41.75M	61.96M	67.09M	65.89M	113.24M	164M	257.74M
Current Ratio	1.82x	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x
Quick Ratio	1.82x	1.32x	2.40x	3.12x	2.94x	3.53x	2.88x	2.11x	1.75x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.58M	44.72M	34.32M	262.23M	257.35M	242M	259.06M	303.92M	475.12M
Long-Term Debt	0	0	13M	232.17M	230.21M	182.92M	203.39M	258.94M	425.3M
Capital Lease Obligations	0	520.26K	517.26K	11.79M	16.18M	14.17M	21.19M	37.32M	31.26M
Deferred Tax Liabilities	43.48K	24.92M	19.62M	18.27M	10.96M	30.14M	14.22M	4.07M	4.55M
Other Non-Current Liabilities	3.54M	19.28M	1.19M	0	0	14.78M	20.26M	3.59M	14M
Total Liabilities	11.02M	154.32M	106.34M	367.65M	372.34M	356.72M	407.67M	522.59M	840.73M
Total Debt+	188.76K	6.25M	13.66M	256.55M	260.56M	200.98M	229.36M	321.01M	471.84M
Net Debt	-9.08M	-113.52M	-93.23M	153.36M	67.08M	-32.11M	-58.66M	27.21M	183.38M
Debt / Equity	0.02x	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x
Debt / EBITDA	-	0.11x	0.12x	5.06x	10.66x	1.74x	1.88x	3.14x	4.02x
Net Debt / EBITDA	-	-2.00x	-0.84x	3.02x	2.75x	-0.28x	-0.48x	0.27x	1.56x
Interest Coverage	-12.14x	471.56x	164.55x	6.85x	2.41x	18.20x	13.16x	5.25x	2.70x
Total Equity+	8.55M	336.31M	406.66M	361.06M	445.15M	510.64M	558.55M	410.77M	514.17M
Equity Growth %	-	38.33%	0.21%	-0.11%	0.23%	0.15%	0.09%	-0.26%	0.25%
Book Value per Share	1.64	11.73	10.73	9.92	11.89	11.25	12.25	8.73	10.66
Total Shareholders' Equity	5.81M	159.95M	180.55M	191.55M	330.82M	448.17M	542.56M	614.22M	712.72M
Common Stock	5.88K	32.3K	34.58K	36K	42K	45K	47K	47K	48K
Retained Earnings	-28.68M	1.73M	17.79M	31.91M	69.77M	137.25M	182.42M	243.13M	286.28M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-5.88K	0	0	0	0	0	0	0	0
Minority Interest	2.74M	176.37M	226.12M	169.51M	114.32M	62.48M	15.99M	-203.45M	-198.55M

Cash Flow

	Mar 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.84M	53.07M	26.1M	13.67M	46.16M	70.33M	82.13M	68.23M	52.2M
Operating CF Margin %	-0.04%	0.15%	0.05%	0.02%	0.12%	0.09%	0.07%	0.05%	0.03%
Operating CF Growth %	-	29.86%	-0.51%	-0.48%	2.38%	0.52%	0.17%	-0.17%	-0.23%
Net Income	-9.34M	25.8M	10.84M	17.67M	122.08M	46.05M	45.74M	57.85M	49.93M
Depreciation & Amortization	351.4K	19.08M	19.3M	18.28M	18.35M	17.52M	17.54M	17.75M	27.93M
Stock-Based Compensation	0	0	0	1.55M	3.38M	6.75M	16.1M	22.04M	34.54M
Deferred Taxes	-127.73K	-20.68M	-8.35M	-6.8M	396K	7.67M	-14.28M	-12.44M	-4.25M
Other Non-Cash Items	4.05M	42.15M	157.26M	5.75M	-102.08M	25.98M	18.98M	6.42M	7.67M
Working Capital Changes	2.63M	15.98M	-63.05M	-22.77M	4.04M	-33.64M	-1.96M	-23.39M	-63.61M
Change in Receivables	272.4K	10.7M	-28.63M	-5.8M	3.01M	-21.63M	-33.97M	-20.57M	-11.1M
Change in Inventory	0	0	0	0	-7.71M	-2.11M	27.61M	12.15M	0
Change in Payables	1.02M	-1.81M	-22.67M	-4.39M	15.82M	4.11M	-2.52M	-498K	-30.43M
Cash from Investing+	-247.11K	6.73M	-25.76M	-180.63M	95.49M	16.54M	-7.11M	-65.52M	-192.4M
Capital Expenditures	-262.11K	-2.08M	-1.17M	-1.04M	-1.16M	-19.22M	-22.94M	-28.53M	-8.03M
CapEx % of Revenue	0.01%	0.01%	0%	0%	0%	0.02%	0.02%	0.02%	0%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	26.8M	-7.5M	-11.19M	16.41M	56K	4.47M	-23.8M	-25.74M
Cash from Financing+	6.34M	-14.98M	-11.2M	163.33M	-51.7M	-47.75M	-20.09M	3.42M	135.15M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-10.45M	-17.76M	-61.72M	-51.32M	-31.09M	-14.03M	-62.07M	-4.04M
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-954.49K	-9M	323	-2.62M	-1.04M	-1.42M	4.02M	-5.01M	-12.59M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.1M	50.99M	24.93M	12.63M	45M	51.11M	59.19M	39.7M	44.17M
FCF Margin %	-0.05%	0.14%	0.05%	0.02%	0.12%	0.07%	0.05%	0.03%	0.02%
FCF Growth %	-	25.27%	-0.51%	-0.49%	2.56%	0.14%	0.16%	-0.33%	0.11%
FCF per Share	-0.40	1.78	0.66	0.35	1.20	1.13	1.30	0.84	0.92
FCF Conversion (FCF/Net Income)	0.20x	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x
Interest Paid	176.59K	51.04K	462K	4.26M	8.51M	4.16M	6.67M	14.25M	30.42M
Taxes Paid	521.34K	24.36M	23.64M	20.2M	62M	37.2M	47.31M	56.57M	43.94M

Key Ratios

Metric	2015	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-109.27%	14.96%	2.92%	3.68%	-5.89%	14.42%	8.45%	12.53%	9.33%
Return on Invested Capital (ROIC)	-	25.36%	25.8%	5.87%	0.89%	14.86%	15.98%	13.53%	11.8%
Gross Margin	22.01%	17.89%	26.83%	16.56%	5.86%	22.97%	17.43%	15.5%	13.34%
Net Margin	-21.21%	7.21%	2.08%	2.52%	-6.42%	8.91%	3.95%	4.38%	2.12%
Debt / Equity	0.02x	0.02x	0.03x	0.71x	0.59x	0.39x	0.41x	0.78x	0.92x
Interest Coverage	-12.14x	471.56x	164.55x	6.85x	2.41x	18.20x	13.16x	5.25x	2.70x
FCF Conversion	0.20x	2.06x	2.41x	0.97x	-1.94x	1.02x	1.82x	1.12x	1.21x
Revenue Growth	-	712.16%	45.33%	7.83%	-33.96%	109.03%	47.84%	21.19%	46.72%

Revenue by Segment

	2024
Health Care Capitation Revenue	1.86B
Health Care Capitation Revenue Growth	-
Health Care, Other	86.22M
Health Care, Other Growth	-
Health Care, Patient Service	62.33M
Health Care, Patient Service Growth	-
Product and Service, Other	15.22M
Product and Service, Other Growth	-
Management Service	13.98M
Management Service Growth	-

Frequently Asked Questions

Valuation & Price

Astrana Health, Inc. (ASTH) has a price-to-earnings (P/E) ratio of 30.4x. This suggests investors expect higher future growth.

Growth & Financials

Astrana Health, Inc. (ASTH) reported $2.90B in revenue for fiscal year 2024. This represents a 6476% increase from $44.0M in 2015.

Astrana Health, Inc. (ASTH) grew revenue by 46.7% over the past year. This is strong growth.

Yes, Astrana Health, Inc. (ASTH) is profitable, generating $9.5M in net income for fiscal year 2024 (2.1% net margin).

Dividend & Returns

Yes, Astrana Health, Inc. (ASTH) pays a dividend with a yield of 0.31%. This makes it attractive for income-focused investors.

Astrana Health, Inc. (ASTH) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.

Astrana Health, Inc. (ASTH) generated $97.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.